Top Suppliers:I want be here
Related CAS#:
88426-33-9 86790-15-0
1158522-08-7 940364-43-2
321433-36-7 134104-43-1
394233-98-8 131615-57-1
6906-52-1 930439-75-1
905684-57-3 941909-46-2

88426-33-9

88426-33-9 structure
88426-33-9 structure
  • Name: Buparvaquone
  • Chemical Name: 3-[(4-tert-butylcyclohexyl)methyl]-4-hydroxynaphthalene-1,2-dione
  • CAS Number: 88426-33-9
  • Molecular Formula: C21H26O3
  • Molecular Weight: 326.429
  • Catalog: Organic raw materials Terpenoid
  • Create Date: 2018-06-27 11:47:43
  • Modify Date: 2024-01-02 22:22:16
  • Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone.
Name 3-[(4-tert-butylcyclohexyl)methyl]-4-hydroxynaphthalene-1,2-dione
Synonyms 2-[(4-tert-butylcyclohexyl)methyl]-3-hydroxynaphthalene-1,4-dione
2-[[4-(1,1-Dimethylethyl)cyclohexyl]methyl]-3-hydroxy-1,4-naphthalenedione
Butalex
UNII-0354RT7LG4
1,4-Naphthalenedione, 2-[[4-(1,1-dimethylethyl)cyclohexyl]methyl]-3-hydroxy-
2-[(4-tert-Butylcyclohexyl)methyl]-3-hydroxynaphthalen-1,4-dion
2-((4-tert-Butylcyclohexyl)methyl)-3-hydroxy-1,4-naphthochinon
BW 720C
Buparvaquone
Buparvaquonum [Latin]
Buparvacuona [Spanish]
3-(4-t-Butylcyclohexyl)methyl-2-hydroxy-1,4-naphthoquinone
MFCD01712789
2-((4-(1,1-Dimethylethyl)cyclohexyl)methyl)-3-hydroxy-1,4-naphthalenedione
2-[(4-tert-Butylcyclohexyl)methyl]-3-hydroxy-1,4-naphthoquinone
2-Hydroxy-3-{[4-(2-methyl-2-propanyl)cyclohexyl]methyl}-1,4-naphthoquinone
2-((4-tert-Butylcyclohexyl)methyl)-3-hydroxy-1,4-naphthoquinone
1,4-Naphthalenedione, 2-((4-(1,1-dimethylethyl)cyclohexyl)methyl)-3-hydroxy-
Description Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone.
Related Catalog
In Vitro In 4-day proliferation assays, buparvaquone efficiently inhibits N. caninum tachyzoite replication(IC50=4.9 nM; IC100=100 nM)[1]. Buparvaquone is significantly selective against L. (L.) infantum chagasi intracellular amastigotes, with an IC50 value of 1.5 μM. Other cutaneous species are also susceptible to buparvaquone, with IC50 values in the range 1-4 μM[2].
In Vivo Treatment of N. caninum infected mice with buparvaquone (100 mg/kg) either by intraperitoneal injection or gavage prevents neosporosis symptoms in 4 out of 6 mice in the intraperitoneally treated group, and in 6 out of 7 mice in the group receiving oral treatment[1]. Both a hydrous gel and water-in-oil emulsion of buparvaquone significantly reduce cutaneous parasite burden and lesion size, compared with the untreated control[3].
Cell Assay To study whether pretreatment of host cells prior to invasion had any effect on parasite proliferation, confluent HFF grown in 6-well plates are treated with 1 µM buparvaquone in medium for 1 h or 5 h, and controls are exposed to the corresponding amounts of DMSO. Subsequently, the drug-containing medium is removed and monolayers are ished 4 times with Hank's Balanced Salt Solution, and are infected with Nc-Liv tachyzoites in 5 mL medium without any drug or solvent. After 2 days, cells are collected with a cell scraper, centrifuged, ished once more in PBS, and the pellet is stored at −20 °C prior to quantification of N. caninum proliferation by N. caninum-specific real time PCR as outlined below[1].
Animal Admin Mice: On day 0, all mice are infected by intraperitoneal (i.p.) injection of freshly purified N. caninum tachyzoites. After 48 h, mice receive BPQ (100 mg/kg) as suspension in corn oil either by i.p. injection of a volume of 100 µl or by oral application of 100 µl by gavage. The control groups obtained the corresponding amount of the solvent only, either i.p. or orally (see Table 2). The treatments are performed 5 times on a daily basis. If not indicated otherwise, mice are inspected twice daily for clinical signs (ruffled coat, apathy, hind limb paralysis) until day 21 post infection (p.i.), at which time they are euthanized[1].
References

[1]. Müller J, et al. Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice. Int J Parasitol Drugs Drug Resist. 2015 Feb 13;5(1):16-25.

[2]. Reimão JQ, et al. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi. Exp Parasitol. 2012 Mar;130(3):195-9.

[3]. Garnier T, et al. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs. J Antimicrob Chemother. 2007 Oct;60(4):802-10.

Density 1.2±0.1 g/cm3
Boiling Point 460.7±45.0 °C at 760 mmHg
Melting Point 178-184ºC
Molecular Formula C21H26O3
Molecular Weight 326.429
Flash Point 246.5±25.2 °C
Exact Mass 326.188202
PSA 54.37000
LogP 6.45
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.574
Storage condition Refrigerator

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QJ5766600
CHEMICAL NAME :
1,4-Naphthalenedione, 2-((4-(1,1-dimethylethyl)cyclohexyl)methyl)-3-hydroxy -
CAS REGISTRY NUMBER :
88426-33-9
LAST UPDATED :
199612
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C21-H26-O3
MOLECULAR WEIGHT :
326.47

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PARAAE Parasitology. (Cambridge University Press, The Edinburgh Bldg., Shaftesbury Rd., Cambridge, CB2 2RU, United Kingdom) V.1- 1908- Volume(issue)/page/year: 90,45,1985
RIDADR NONH for all modes of transport
RTECS QJ5766600

Chemsrc provides CAS#:88426-33-9 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 88426-33-9 | Chemsrc address: https://m.chemsrc.com/en/baike/511817.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved